General description
Pyridostigmine bromide is a cholinesterase inhibitor used in the treatment of myasthenia gravis.
INN
Pyridostigmine bromide
ATC codes
Medicine type
Chemical agent
EML status history
First added in 1977
(TRS
615)
for
Myasthenia gravis
Wikipedia
DrugBank
Recommendations
Section
Muscle relaxants (peripherally-acting) and cholinesterase inhibitors
- Parenteral > General injections > IV: 1 mg in 1 mL ampoule (pyridostigmine bromide)
- Oral > Solid: 60 mg (pyridostigmine bromide)
Indications